Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Rheumatology Advances in Practice|August 22, 2022
Does periodontal treatment improve rheumatoid arthritis disease activity? A systematic reviewZhain Mustufvi, Joshua Twigg, Joel Kerry, et al.
Clinical Medicine (London, England)|August 7, 2025
Immune checkpoint inhibitor-induced inflammatory arthritisBenjamin A Fisher, Andrew Allard, Shirish Dubey, et al.
Rheumatology (Oxford, England)|December 14, 2020
Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritisChristopher M Rooney, Kulveer Mankia, Suparna Mitra, et al.
Clinical and Experimental Rheumatology|June 14, 2022
Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?Hanna L Gul, Andrea Di Matteo, Kulveer Mankia, et al.
The Journal of Bone and Joint Surgery. American Volume|February 17, 2022
The Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Drugs on the Risk of Postoperative Complications: Surgical Site Infection, Delayed Wound Healing, and Disease Flares Following Orthopaedic Surgical ProceduresBernard H van Duren, Alice Wignall, Susan Goodman, et al.
The Journal of Rheumatology|February 1, 2024
Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without ArthritisCecilia Hemgren, Klara Martinsson, Christopher Rooney, et al.
ACR Open Rheumatology|February 27, 2024
Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable TherapyHanna Gul, Andrea Di Matteo, Innocent Anioke, et al.
Rheumatology (Oxford, England)|October 1, 2025
Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-upKerem Abacar, Andrea Di Matteo, Paula David, et al.
Frontiers in Medicine|August 21, 2023
Antibodies to leukotoxin A from the periodontal pathogen <i>Aggregatibacter actinomycetemcomitans</i> in patients at an increased risk of rheumatoid arthritisKlara Martinsson, Andrea Di Matteo, Carina Öhman, et al.
RMD Open|February 15, 2026
Development of the 'COuld it Be RA' (COBRA) tool to facilitate early identification of people at risk of developing rheumatoid arthritis in primary careHeidi J Siddle, Anna M Anderson, Elizabeth M A Hensor, et al.
Pageof 8